Literature DB >> 26944586

Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.

Ben Ma1, Yu Wang2, Shuwen Yang1, Qinghai Ji1.   

Abstract

BACKGROUND AND OBJECTIVES: Recently, some single-institution studies have reported risk factors of CLNM in cN0 PTC patients, but results from those studies are not consistent. The meta-analysis aimed to identify some risk factors that can be predictive of CLNM in cN0 PTC patients.
METHODS: We performed a systematic search for relevant literature published prior to December 2015 using the following search engines: PubMed, EMBASE, Ovid and Web of Science. We included retrospective, prospective, and observational studies that investigated the risk factors for CLNM in patients with cN0 PTC.
RESULTS: Thirty-one studies, including 37,355 patients with cN0 PTC from seven countries were included in the meta-analysis. The pooled analysis indicated that age<45 years (OR = 1.57, 95%CI:1.48-1.66, P < 0.001), male gender (OR = 1.79, 95%CI: 1.69-1.91, P < 0.001), tumor size>10 mm (OR = 2.61, 95%CI:2.27-3.00, P < 0.001), bilaterality (OR = 1.52, 95%CI:1.31-1.77, P < 0.001), multifocality (OR = 1.46, 95%CI: 1.31-1.61, P < 0.001), extracapsular invasion (OR = 2.10, 95%CI:1.81-2.43, P < 0.001), angiolymphatic invasion (OR = 8.02, 95%CI:5.00-12.87, P < 0.001), high histologic risk (OR = 2.62, 95%CI:2.13-3.22, P < 0.001) and BRAF(V600E) mutation (OR:1.78, 95%CI:1.38-2.30, P < 0.001) were significantly associated with CLNM, and upper third location (OR = 0.54, 95%CI:0.43-0.67, P < 0.001) and lymphocytic thyroiditis (OR = 0.64, 95%CI:0.42-0.97, P = 0.034) were decreased risk factors of CLNM.
CONCLUSIONS: We identified several predictive factors for CLNM in cN0 PTC patients. Some certain risk factors could be considered in preoperative clinical decision regarding the necessity of prophylactic central lymph node dissection in cN0 PTC patients.
Copyright © 2016 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRAF(V600E); CLNM; Meta-analysis; PTC

Mesh:

Substances:

Year:  2016        PMID: 26944586     DOI: 10.1016/j.ijsu.2016.02.093

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  28 in total

1.  Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence.

Authors:  Pietro Giorgio Calò; Celestino Pio Lombardi; Francesco Podda; Luca Sessa; Luigi Santini; Giovanni Conzo
Journal:  Updates Surg       Date:  2017-04-13

2.  Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.

Authors:  Xiang Zhong; Yunpeng Lu; Xu Yin; Quhui Wang; Feiran Wang; Zhixian He
Journal:  Gland Surg       Date:  2022-02

3.  Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis.

Authors:  Jing-Yong Song; Shi-Ran Sun; Fang Dong; Tao Huang; Bin Wu; Jing Zhou
Journal:  Curr Med Sci       Date:  2018-10-20

4.  Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.

Authors:  Y Feng; Y Min; H Chen; K Xiang; X Wang; G Yin
Journal:  J Endocrinol Invest       Date:  2021-02-14       Impact factor: 4.256

5.  To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma.

Authors:  Jiru Yuan; Gang Zhao; Jialin Du; Xiaoyi Chen; Xiaodong Lin; Zhengbo Chen; Zeyu Wu
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

6.  MiR-324-5p assists ultrasonography in predicting lymph node metastasis of unifocal papillary thyroid microcarcinoma without extracapsular spread.

Authors:  Yanhua Yang; Shujun Xia; Xiaofeng Ni; Zhongxin Ni; Lu Zhang; Wenhan Wang; Yanjun Kong; Yan Wang; Lei Ye; Weiwei Zhan
Journal:  Oncotarget       Date:  2017-07-31

7.  Twisted Gastrulation BMP Signaling Modulator 1 Regulates Papillary Thyroid Cancer Cell Motility and Proliferation.

Authors:  Shujun Xia; Ri Ji; Yongmin Xu; Xiaofeng Ni; Yijie Dong; Weiwei Zhan
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

8.  Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis.

Authors:  Young Min Park; Sang Min Lee; Dong Won Kim; Sung-Chan Shin; Byung-Joo Lee
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

9.  Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature.

Authors:  J Liang; Z Li; F Fang; T Yu; S Li
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-02       Impact factor: 2.124

10.  Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.

Authors:  Jianhao Huang; Muye Song; Hongyan Shi; Ziyang Huang; Shujie Wang; Ying Yin; Yijie Huang; Jialin Du; Sanming Wang; Yongchen Liu; Zeyu Wu
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.